Genelux Common Valuation
| GNLX Stock | 3.48 0.13 3.88% |
At this time, the firm appears to be overvalued. Genelux Common retains a regular Real Value of USD3.34 per share. The prevalent price of the firm is USD3.48. Our model calculates the value of Genelux Common from evaluating the firm fundamentals such as Shares Owned By Insiders of 22.30 %, operating margin of (142.15) %, and Return On Asset of -0.9 as well as inspecting its technical indicators and probability of bankruptcy. In general, most investors encourage acquiring undervalued assets and dropping overvalued assets since, at some point, asset prices and their ongoing real values will come together. Key fundamental drivers impacting Genelux Common's valuation include:
Price Book 5.6841 | Enterprise Value 71.3 M | Enterprise Value Ebitda (3.40) | Price Sales 651.0933 | Enterprise Value Revenue 529.4926 |
Overvalued
Today
Please note that Genelux Common's price fluctuation is very risky at this time. Calculation of the real value of Genelux Common is based on 3 months time horizon. Increasing Genelux Common's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Genelux Common is useful when determining the fair value of the Genelux stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Genelux Common. Since Genelux Common is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Genelux Stock. However, Genelux Common's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 3.48 | Real 3.34 | Target 34.33 | Hype 3.48 | Naive 3.46 |
The real value of Genelux Stock, also known as its intrinsic value, is the underlying worth of Genelux Common Company, which is reflected in its stock price. It is based on Genelux Common's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Genelux Common's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Genelux Common's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Genelux Common helps investors to forecast how Genelux stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Genelux Common more accurately as focusing exclusively on Genelux Common's fundamentals will not take into account other important factors: Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Genelux Common's intrinsic value based on its ongoing forecasts of Genelux Common's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Genelux Common's closest peers. When choosing an evaluation method for Genelux Common, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.
Genelux Common Investments |
|
Genelux Valuation Trend
Knowing Genelux Common's actual value is paramount for traders to make sound investment determinations. Genelux Common's real value is not only important for the investor to make better decisions but also for a more accurate overall view of Genelux Common's financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both Genelux Common's enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.
Genelux Market Cap
Genelux Common is rated # 2 in market capitalization category among related companies. Market capitalization of Health Care industry is currently estimated at about 372.67 Million. Genelux Common totals roughly 93.49 Million in market capitalization claiming about 25% of equities under Health Care industry.Genelux Common Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining Genelux Common's current stock value. Our valuation model uses many indicators to compare Genelux Common value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Genelux Common competition to find correlations between indicators driving Genelux Common's intrinsic value. More Info.Genelux Common is one of the top stocks in price to book category among related companies. It is one of the top stocks in price to sales category among related companies fabricating about 114.55 of Price To Sales per Price To Book. At this time, Genelux Common's Price To Sales Ratio is fairly stable compared to the past year.Comparative valuation analysis is a catch-all model that can be used if you cannot value Genelux Common by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Genelux Common's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Genelux Common's earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Genelux Common's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Genelux Common and how it compares across the competition.
About Genelux Common Valuation
The stock valuation mechanism determines the current worth of Genelux Common on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Genelux Common. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Genelux Common based exclusively on its fundamental and basic technical indicators. By analyzing Genelux Common's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Genelux Common's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Genelux Common. We calculate exposure to Genelux Common's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Genelux Common's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -848 K | -805.6 K | |
| Pretax Profit Margin | (166.45) | (174.78) | |
| Operating Profit Margin | (142.15) | (149.25) | |
| Net Loss | (166.45) | (174.78) | |
| Gross Profit Margin | (4.99) | (4.74) |
8 Steps to conduct Genelux Common's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Genelux Common's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Genelux Common's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Genelux Common's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Genelux Common's revenue streams: Identify Genelux Common's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Genelux Common's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Genelux Common's growth potential: Evaluate Genelux Common's management, business model, and growth potential.
- Determine Genelux Common's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Genelux Common's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Genelux Common Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Genelux Common does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 24.4 M |
Genelux Common Current Valuation Indicators
Valuation refers to the process of determining the present value of Genelux Common and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Genelux we look at many different elements of the entity such as Genelux's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. Genelux Common's valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Genelux Common's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Genelux Common, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Genelux Common's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Genelux Common's worth.When determining whether Genelux Common offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Genelux Common's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Genelux Common Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Genelux Common Stock: Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Genelux Common. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. For more information on how to buy Genelux Stock please use our How to Invest in Genelux Common guide.You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Complementary Tools for Genelux Stock analysis
When running Genelux Common's price analysis, check to measure Genelux Common's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genelux Common is operating at the current time. Most of Genelux Common's value examination focuses on studying past and present price action to predict the probability of Genelux Common's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genelux Common's price. Additionally, you may evaluate how the addition of Genelux Common to your portfolios can decrease your overall portfolio volatility.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |
Is Genelux Common's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Genelux Common. If investors know Genelux will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Genelux Common listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.16) | Revenue Per Share 0.007 | Quarterly Revenue Growth (1.00) | Return On Assets (0.90) |
The market value of Genelux Common is measured differently than its book value, which is the value of Genelux that is recorded on the company's balance sheet. Investors also form their own opinion of Genelux Common's value that differs from its market value or its book value, called intrinsic value, which is Genelux Common's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Genelux Common's market value can be influenced by many factors that don't directly affect Genelux Common's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Genelux Common's value and its price as these two are different measures arrived at by different means. Investors typically determine if Genelux Common is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Genelux Common's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.